Insilico Medicine (03696) has announced a new partnership with a leading foundation model laboratory, securing a collaboration contract valued at up to tens of millions of dollars. The agreement focuses on co-developing, validating, and commercializing a suite of advanced foundation models designed specifically for biological research, leveraging the MMAI Gym training framework.

Under the terms of the deal, both parties will integrate their respective strengths to construct specialized foundation models tailored for generative biology. Insilico Medicine will contribute proprietary datasets covering a range of specialized life science tasks and will conduct closed-loop wet-lab validation on the outputs generated by these foundation models during their training phase.

Furthermore, the collaboration establishes a revenue-sharing model designed to drive global commercialization efforts by tapping into each partner's extensive networks within the biopharmaceutical industry. This strategic alliance underscores a shared commitment to accelerating innovation at the intersection of artificial intelligence and life sciences.